Discontinued — last reported Q2 '16
Accenture Change in AR decreased by 10.3% to $1.10B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.3%, from $1.23B to $1.10B. This is a positive signal — lower values indicate better performance for this metric.
An increase in receivables relative to revenue may signal slower collections or aggressive revenue recognition, while a decrease suggests improved cash flow efficiency.
This represents the net change in the balance of amounts owed to the company by customers for goods or services delivere...
Standard working capital metric; peers in pharmaceuticals monitor this closely to track payer reimbursement cycles.
is_anet_change_in_accounts_receivable| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $1.35B | $609.43M | $836.23M | $1.23B | $1.10B |
| QoQ Change | — | -55.0% | +37.2% | +46.5% | -10.3% |
| YoY Change | — | -55.0% | +37.2% | +46.5% | -10.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.